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KOCHI: The Central Marine Fisheries 
Research Institute (CMFRI) here has 
developed an anti-obesity nutraceutical from 
the seaweeds. 
 
Cadalmin (TM) Anti-hypercholesterolemic 
extract (CadalminTM ACe)is a natural 
remedy for obesity and dyslipidemia. And 
Governor P Sathasivam will launch it during 
the inauguration of the CMFRI Platinum 
Jubilee here on Saturday. 
The CMFRI scientists had produced the extract from the seaweeds commonly available in the 
country’s seas. 
Dr Kajal Chakraborty, senior scientist in the Marine Biotechnology Division, who developed 
the product,said bioactive pharmacophore leads from the seaweeds were used to prepare the 
nutraceutical product. 
“CadalminTM Antihypercholesterolemic extract can be administered to regulate clinical 
indicators leading to dyslipidemia or obesity, total adipose tissue and visceral fat, 
triglycerides, cholesterol, both good and bad, known as HDL and LDL. It contains 100 per 
cent natural marine bioactive ingredients from selected seaweeds and would be made 
available in 400 mg capsules,” he said. 
According to Dr Chakraborty,”The nutraceutical does not have any side effects as shown in 
the preclinical trials”. 
Dr P Vijayagopal, Head, Marine Biotechnology Division said the active ingredients in the 
product would be packed in capsules to meet the dietary needs of the large vegetarian 
population in India and abroad. 
“CadalminTM Antihypercholesterolemic extract has a promising consumer appeal and 
market potential especially for the sizeable vegetarian population in India and abroad,” he 
said. CadalminTM Antihypercholesterolemic extract is the fourth nutraceutical product 
developed by the CMFRI. 
